A retrospective study by Lee and Padgett compared BPC-157 alone to BPC-157 combined with thymosin beta-4 for knee injections, finding potential additive benefits from the combination
How BPC-157 Works: Mechanisms of Action Researchers have identified several interconnected ways BPC-157 may work: Tissue Repair & Regeneration: It may stimulate growth factors and signaling pathways involved in repairing tendons, ligaments, muscles and bone
Its gastroprotective effects involve upregulation of EGF receptor signalling and prostaglandin pathways in GI mucosa, explaining its longstanding use as a gastric mucosal protective agent in preclinical ulcer and colitis models
[DOI] [PMC free article] [PubMed] [Google Scholar] 32.Blher M., Rosenstock J., Hoefler J., Manuel R., Hennige A.M
As of now, BPC-157 has not received approval by the Food and Drug Administration (FDA) for clinical use